Project 1: Vimentin regulates host response and repair mechanisms to influenza A viral pneumonia
项目1:波形蛋白调节宿主对甲型流感病毒性肺炎的反应和修复机制
基本信息
- 批准号:10696962
- 负责人:
- 金额:$ 51.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcuteAcute Respiratory Distress SyndromeAdenosineAlveolar MacrophagesAmphiregulinAntibodiesAutomobile DrivingCOVID-19COVID-19 patientCOVID-19 pneumoniaCellsClinicalCredentialingDataEpidermal Growth FactorEpitheliumEtiologyExhibitsFailureFlow CytometryFundingFunding OpportunitiesGene ExpressionGene Expression ProfileGenesIL18 geneImmune responseImpairmentInfectionInflammasomeInflammationInflammatoryInflammatory ResponseInfluenza A virusInstructionInterleukin-1 betaIntermediate FilamentsKnockout MiceLower respiratory tract structureLungMacrophageMediatingMetabolicMonoclonal AntibodiesMorbidity - disease rateMusNational Institute of Allergy and Infectious DiseaseOutcomePatientsPhenotypePlayPneumoniaProcessProductionProliferatingPulmonary InflammationRecoveryRegulatory T-LymphocyteReportingResearchResolutionRespiratory FailureRoleSignal TransductionStructure of parenchyma of lungTechniquesTestingTissuesVimentinViralViral PneumoniaVirusVirus Diseaseschemokineclinically relevantcommunity acquired pneumoniaconditional knockoutcytokinedepolymerizationexperimental studyextracellularimprovedinfluenza infectioninjury and repairlung injurylung repairmonocytemortalitymouse modelnovelparticipant enrollmentpathogenplacebo controlled trialpreventrecruitrepair functionrepairedtargeted treatmenttissue repair
项目摘要
PROJECT SUMMARY PROJECT 1
Severe viral pneumonia, due to influenza A virus (IAV) damages the lower respiratory tract to cause acute
respiratory distress syndrome (ARDS). The persistence of respiratory failure in patients with ARDS is a
consequence of persistent inflammation and the failure of normal mechanisms of inflammation resolution and
lung tissue repair. A crucial step in the immune response to IAV is the activation of the NLRP3 inflammasome
and subsequent secretion of inflammatory cytokines, IL-1β and IL-18.
Vimentin regulates the formation and activation of the NLRP3 inflammasome. We propose to modulate the NLRP3 inflammasome by temporally deleting vimentin in monocyte-derived alveolar macrophages (MoAMs) post-viral clearance in IAV-infected mice.
MoAMs play crucial roles in both initiation and continuation of the immune response, limiting repair of the injured
lung tissue. Our data revealed that genes driving the inflammatory phenotype are suppressed in Vimentin−/−
MoAMs. Using novel lineage-tracing techniques in inducible conditional knockout mice, we will investigate
whether vimentin regulates persistent inflammation by promoting an inflammatory phenotype in MoAMs following
clearance of IAV. Regulatory T cells also contribute to recovery from viral pneumonia by suppressing immune
responses and promoting lung tissue repair. Our data suggest that Vimentin−/− Treg cells exhibit a cell-
autonomous increase in their pro-repair function following IAV infection. We hypothesize that a targeted loss
of vimentin in alveolar macrophages and regulatory T cells is required to promote pro-repair processes
following severe IAV infection.
Specific Aim 1. To determine whether a targeted loss of vimentin in monocyte-derived alveolar
macrophages suppresses their inflammatory response and promotes lung repair following severe
influenza infection. We propose to disrupt the persistent inflammation that limits repair of injured lung tissue by
temporally-controlled deletion of vimentin in monocyte-derived alveolar macrophages post-viral clearance in IAV-
infected mice.
Specific Aim 2. To determine whether depolymerization of vimentin intermediate filaments causes
metabolic reprogramming to suppress alveolar macrophage inflammatory phenotype. Our preliminary
data suggest that a switch from inflammatory to pro-repair macrophage phenotype is associated with metabolic
reprogramming and depolymerization of vimentin intermediate filaments.
Specific Aim 3. To determine whether temporal, cell-specific loss of vimentin augments the pro-repair
function of regulatory T cells during recovery from IAV-induced pneumonia. We propose to determine
whether Vimentin−/− Treg cells exhibit their augmented cell-autonomous pro-repair function via increased
adenosine signaling and amphiregulin production following influenza A virus infection.
项目1
严重的病毒性肺炎,由于甲型流感病毒(IAV)破坏下呼吸道引起急性
呼吸窘迫综合征(ARDS)。急性呼吸窘迫综合征患者呼吸衰竭的持续存在是一个重要的因素。
持续性炎症的后果和炎症消退的正常机制的失败,
肺组织修复。对IAV的免疫应答中的关键步骤是NLRP 3炎性体的激活
以及随后分泌炎性细胞因子IL-1β和IL-18。
波形蛋白调节NLRP 3炎性体的形成和活化。我们建议通过暂时删除IAV感染小鼠病毒清除后单核细胞衍生的肺泡巨噬细胞(MoAM)中的波形蛋白来调节NLRP 3炎性体。
MoAM在免疫应答的启动和持续中起着至关重要的作用,限制了损伤的修复。
肺组织我们的数据显示,驱动炎症表型的基因在波形蛋白−/−中受到抑制,
MoAM。在诱导型条件性基因敲除小鼠中使用新的谱系追踪技术,我们将研究
波形蛋白是否通过促进MoAM中的炎症表型来调节持续性炎症
清除IAV。调节性T细胞还通过抑制免疫应答,
反应和促进肺组织修复。我们的数据表明波形蛋白-/-Treg细胞表现出细胞-
IAV感染后,其促修复功能的自主增加。我们假设有针对性的损失
肺泡巨噬细胞和调节性T细胞中的波形蛋白是促进前修复过程所必需的
严重的IAV感染。
具体目标1。为了确定波形蛋白在单核细胞源性肺泡上皮细胞中的靶向丢失是否是
巨噬细胞抑制它们的炎症反应,并促进严重肺损伤后的肺修复。
流感感染。我们建议通过以下方法破坏持续性炎症,这种炎症限制了受损肺组织的修复:
IAV中病毒清除后单核细胞衍生的肺泡巨噬细胞中波形蛋白的时间控制缺失-
感染的老鼠
具体目标2。为了确定波形蛋白中间丝的解聚是否导致
代谢重编程以抑制肺泡巨噬细胞炎性表型。我们的初步
数据表明,从炎症巨噬细胞表型到促修复巨噬细胞表型的转变与代谢相关,
波形蛋白中间丝的重编程和解聚。
具体目标3。为了确定波形蛋白的暂时的、细胞特异性的缺失是否增强了前修复,
调节性T细胞在从IAV诱导的肺炎中恢复期间的功能。我们建议确定
波形蛋白-/-Treg细胞是否通过增加细胞自主修复功能来增强其功能,
流感病毒感染后腺苷信号传导和双调蛋白的产生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAREN M RIDGE其他文献
KAREN M RIDGE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAREN M RIDGE', 18)}}的其他基金
Project 1: Vimentin regulates host response and repair mechanisms to influenza A viral pneumonia
项目1:波形蛋白调节宿主对甲型流感病毒性肺炎的反应和修复机制
- 批准号:
10269674 - 财政年份:2021
- 资助金额:
$ 51.66万 - 项目类别:
Vimentin-mediated regulation of the inflammasome in acute lung injury
波形蛋白介导的急性肺损伤炎症小体的调节
- 批准号:
9251880 - 财政年份:2016
- 资助金额:
$ 51.66万 - 项目类别:
Role of vimentin in influenza A-induced acute lung injury
波形蛋白在甲型流感引起的急性肺损伤中的作用
- 批准号:
8775974 - 财政年份:2014
- 资助金额:
$ 51.66万 - 项目类别:
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 51.66万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 51.66万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 51.66万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 51.66万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 51.66万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 51.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 51.66万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 51.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 51.66万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 51.66万 - 项目类别: